The corporate selected is having status as amalgamated hence financial data is not available. You may check its last filed documents by making a request.
About
Basic Data Updated:
5 months agoIndustry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24232UP2004PLC029009 |
| Company No. | 029009 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 30 Aug 2004 |
| Date of AGM | 23 Sep 2019 |
| Date of Balance Sheet | 31 Mar 2019 |
| Listing Status | Unlisted |
| ROC Code | Roc Kanpur |
Products or Services related to Jubilant Chemsys Limited
Laboratory Testing Services
Data Processing
Reference Books
Pharmaceutical Services
Financials of Jubilant Chemsys Limited
Jubilant Chemsys Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 23.77% increase. The company also saw a substantial improvement in profitability, with a 23.08% increase in profit. The company's net worth Soared by an impressive increase of 15.75%.
Corporate Structure
Unlock access to Jubilant Chemsys's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Jubilant Chemsys Limited
Unlock and access historical data on people associated with Jubilant Chemsys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (2)
VS
Vikas Shirsath
Managing DirectorAppointment Date: 29-Apr-2013
Status: Current
NA
Noopur Agarwal Company SecretaryStatus: Current
Board Members(4)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ing Vysya Bank Limited Creation Date: 28 Nov 2005 | ₹5.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jubilant Chemsys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jubilant Chemsys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
15 years 11 days 
Recent activity within the organization
Director Appointment
Anant Pande was appointed as a Additional Director was appointed as a Additional Director on 28 Nov 2019 & has been associated with this company since 4 years 9 months .
28 Nov 2019Annual General Meeting
Jubilant Chemsys Limited last Annual general meeting of members was held on 23 Sep 2019 as per latest MCA records.
23 Sep 2019Balance Sheet
Jubilant Chemsys Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Kanpur.
31 Mar 2019Director Appointment
Arun Kumar Sharma was appointed as a Director was appointed as a Director on 03 Oct 2018 & has been associated with this company since 5 years 11 months .
03 Oct 2018Director Appointment
Marcellus Johannes Velterop was appointed as a Director was appointed as a Director on 03 Oct 2018 & has been associated with this company since 5 years 11 months .
03 Oct 2018
Recent News, Updates & Announcement
Pharma company Jubilant Biosys plans to expand India footprint to foray into new therapeutic areas says CEO Giuliano Perfetti.The company which is a Contract Research Development and Manufacturing Organisation CRDMO offers comprehensive drug discovery development and manufacturing services to global healthcare companies.
Business Today 29 Feb 2024
- Jubilant Biosys is first to add ForteBios latest SPR System in India for fragment screening and characterization of lead compounds.
PRNewswire Jubilant Biosys a wholly owned subsidiary of Jubilant Life Sciences announced today that it has recently added advanced Pioneer FE system to.
PR Newswire 20 May 2019
- Jubilant Biosys Selects CDD Vault to Communicate Research Data With Customers for Next Five Years.
PRNewswire Jubilant Biosys and Collaborative Drug Discovery CDD announced today following an exhaustive evaluation Jubilant has chosen CDD Vault as.
PR Newswire 08 May 2019
- Jubilant Biosys is First to add ForteBios Latest SPR System in India for Fragments Screening and Characterization of Lead Compounds.
PRNewswire Jubilant Biosys a subsidiary of Jubilant Life Sciences Ltd announced today that it has added advanced Pioneer FE system to its platform of.
PR Newswire 28 Mar 2019
- When Your Squad Needs BrainBoosting Drugs Jubilant Biosys Comes to the Rescue BrainPower CollaborationGoals SmallButMighty.
When you and your squad tryna find drugs to cure brain problems Jubilant Biosys a company from Bengaluru is helping us out BrainPower CollaborationGoals SmallButMighty.
PR Newswire 13 Feb 2019
Frequently asked questions
What is the Incorporation or founding date of Jubilant Chemsys Limited?
